Accelerated Drug Discovery & Toxicology: New Approach Methodologies (NAMs) Overview from 2D → 2.5D → 3D Dynamic Tide Motion → 3D Organoid — Animal
At Esco Aster, we believe the best scientific outcomes are achieved through a diverse, complementary toolkit. MiniTide® is offered not as a replacement, but as a high-performance parallel solution that runs alongside traditional 2D and organoid cultures. This approach delivers rapid, high-fidelity data, accelerates decision-making, and significantly de-risks the path to clinical trials.
.webp)
The Evolutionary Workflow
II. Foundational Cultures (2D Monolayer Culture)
- 2D Monolayer Culture: The standard flat plastic culture of cell lines or primary cells derived from patients (e.g., IPF, cancer). Culture duration: 1–7 days
- Air-Liquid Interface (ALI) Culture: Cells grown on porous inserts with basal medium and apical air exposure. Widely used for airway models. Culture duration: 1–7 days
- 2.5D Cell Culture: Cells grown on a flat, often ECM-coated surface or partially embedded in a thin layer of gel, mimicking the extracellular matrix.
III. Advanced NAMs – Dynamic 3D Systems (I Advanced NAMs) MiniTide® & 3D Tide Motion Bioreactor
The Tide Motion system mimics a lung-like microenvironment by cyclically exposing cells to air and culture media. During the Bottom Holding Time (Aeration Phase), carriers remain partially submerged (~20%), creating a stable air-liquid interface.
- Key Benefits: Promotes mucus production, cilia formation, strong epithelial barrier integrity (TEER), and physiologically relevant cell behavior.
- Culture Duration: 1–2 weeks
- Applications: Drug discovery, toxicology testing, lung fibrosis/injury research, cancer cell studies, and pulmonary models.
IV. Advanced NAMs – Complex Models & Ex Vivo (II Advanced NAMs)
- Cells or Spheroid-on-a-Chip: Self-assembling cell clusters in ultra-low attachment plates or hanging drops. Culture duration: 1–3 weeks
- Organoids: Self-organizing 3D mini-organs from stem cells (ESC/iPSC/adult). Culture duration: 2–8+ weeks
- Patient-Derived Organoids: Generated directly from patient tumor/normal biopsies. Culture duration: 2–6 weeks
- Organ-on-a-Chip: Microfluidic devices with 3D cells, flow, and ALI options. Culture duration: 1–3 weeks
- Assembloids: Integrated 3D systems combining multiple organoids or cell lineages. Culture duration: 3–8+ weeks
- Hollow Fiber Systems: Perfused 3D systems for high-density culture and long-term liver/kidney. Culture duration: metabolic modeling. weeks to months
V. In Vivo & Clinical Stages
- Small Animal models (mouse/rat)
- Large Animal models (pig, dog, sheep)
- Non-Human Primates (NHP)
- Patient-Derived Xenograft (PDX)
- Human Clinical Trials – The Ultimate Benchmark
Why MiniTide® The Parallel Advantage
The MiniTide® system is offered as a high-performance parallel option. By running it alongside your current traditional 2D or organoid cultures, you gain a multifaceted view of your data without disrupting established protocols.
The MiniTide® system is a specialized solution for respiratory and toxicology research. By maintaining a "Bottom Holding Time" (Aeration Phase), it promotes:
- Natural cell morphology and function (mucus production, cilia formation)
- Strong epithelial barrier integrity (TEER)
- Expression of key cellular markers (cytokines, ROS)
- Maintenance of the physiological route of exposure
- Highly relevant data for real human inhalation and drug contact
The 3Rs Principles in NAMs
- Parallel Screening Option: Run alongside traditional cultures for immediate early-stage data.
- Rapid Lead Times: Screening readiness in 1–2 weeks.
- Cost-Efficient Alternative: High-throughput at a fraction of the cost ($2k vs. $20k).
- Standardized Protocols: Automated dynamic culture reduces variability and reliance on specialized Matrigel.
Connect with our team today to explore how we can support your next breakthrough from concept to clinic. For inquiries and collaborations, please contact us at [email protected].